Viewing data from:

VECURONIUM BROMIDE

ANDA

VECURONIUM BROMIDE | A206670 | EUGIA PHARMA SPECIALITIES LTD

2 strengths0 unique patents0 unique exclusivities

API Supply Chain4 active DMFs1 inactive

4 active API suppliers hold Drug Master Files for this ingredient.

TAPI NL BVVECURONIUM BROMIDE

DMF 99251992

ZHEJIANG XIANJU PHARMACEUTICAL CO LTDVECURONIUM BROMIDE

DMF 120501996

CURIA ITALY SRLVECURONIUM BROMIDE

DMF 120631996

ASPEN OSS BVVECURONIUM BROMIDE

DMF 200592006

DIOSYNTH BVInactiveVECURONIUM BROMIDE

DMF 120021996

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (2)

Sort:

#001 — 10MG/VIAL

0 patents0 exclusivities▴

INJECTABLE;INJECTION | Approved: Dec 20, 2018

No patent or exclusivity listings for this strength.

#002 — 20MG/VIAL

0 patents0 exclusivities▾

INJECTABLE;INJECTION | Approved: Dec 20, 2018

Change History (2)

Recent changes detected for this application.

MODIFIEDrs7/1/2026

EUGIA PHARMA's vecuronium bromide NDA 206670 (supplement 002) was designated as a restricted distribution drug product.

Old: No

New: Yes

MODIFIEDrs7/1/2026

Vecuronium bromide (EUGIA PHARMA, NDA 206670) gained pediatric exclusivity designation following completion of required pediatric studies.

Old: No

New: Yes